Poor management, not drug costs, is hampering implementation of NICE guidanceBMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7517.594-a (Published 15 September 2005) Cite this as: BMJ 2005;331:594
- Adrian O'Dowd
Poor financial management and not the cost of drugs and treatment is preventing clinicians in England from doing their jobs properly, says the Audit Commission.
The watchdog of public spending claims that much of the guidance issued by the National Institute for Health and Clinical Excellence (NICE) is not implemented because trusts do not organise their finances well enough.
Better communication between clinical and financial staff will help the situation, says the commission in its report on the financial implications of NICE guidance, which was published last week in conjunction with the institute.
Hospitals and primary care trusts could boost clinical excellence if they followed all of NICE's guidance, which is …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial